Puma Biotechnology, Inc.PBYINASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
-0.3%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 51.52% |
| Q3 2025 | 51.05% |
| Q2 2025 | 96.87% |
| Q1 2025 | -84.59% |
| Q4 2024 | -4.98% |
| Q3 2024 | 548.60% |
| Q2 2024 | 5.94% |
| Q1 2024 | -139.25% |
| Q4 2023 | 111.66% |
| Q3 2023 | 172.62% |
| Q2 2023 | 51.75% |
| Q1 2023 | 124.99% |
| Q4 2022 | -1457.22% |
| Q3 2022 | -103.84% |
| Q2 2022 | 375.37% |
| Q1 2022 | -180.56% |
| Q4 2021 | 109.46% |
| Q3 2021 | -774.89% |
| Q2 2021 | -130.89% |
| Q1 2021 | 210.23% |
| Q4 2020 | 52.34% |
| Q3 2020 | -1026.75% |
| Q2 2020 | 120.05% |
| Q1 2020 | -51.20% |
| Q4 2019 | 33.73% |
| Q3 2019 | 54.84% |
| Q2 2019 | -270.53% |
| Q1 2019 | 67.10% |
| Q4 2018 | -116.20% |
| Q3 2018 | 67.97% |
| Q2 2018 | -82.11% |
| Q1 2018 | 62.02% |
| Q4 2017 | 16.95% |
| Q3 2017 | 0.84% |
| Q2 2017 | -6.82% |
| Q1 2017 | -0.23% |
| Q4 2016 | -10.52% |
| Q3 2016 | 1.23% |
| Q2 2016 | 6.16% |
| Q1 2016 | -15.03% |